Should Niacin Be the Preferred Drug to Add to a Statin? Michael H. Davidson Clinical trial report 07 September 2010 Pages: 447 - 449
Have the Renin-Angiotensin-Aldosterone System Perturbations in Cardiovascular Disease Been Exhausted? Sulaf J. MansurFadi G. HageSuzanne Oparil ReviewPaper 09 September 2010 Pages: 450 - 463
The Role of Renin-Angiotensin Agents in Altering the Natural History of Type 2 Diabetes Mellitus Joel A. LardizabalPrakash C. Deedwania ReviewPaper Open access 01 September 2010 Pages: 464 - 471
Advances in Pharmacologic Modulation of Nitric Oxide in Hypertension Yoshiko MizunoRobert F. JacobR. Preston Mason ReviewPaper 01 September 2010 Pages: 472 - 480
Pharmacomodulation of High-Density Lipoprotein Metabolism as a Therapeutic Intervention for Atherosclerotic Disease Peter P. Toth ReviewPaper 26 August 2010 Pages: 481 - 487
Recognizing and Improving Health Care Disparities in the Prevention of Cardiovascular Disease in Women Jennifer L. JarvieJoAnne M. Foody ReviewPaper 24 August 2010 Pages: 488 - 496
New Advances in Noninvasive Imaging of the Carotid Artery: CIMT, Contrast-Enhanced Ultrasound, and Vasa Vasorum Blai CollVijay NambiSteven B. Feinstein ReviewPaper 27 August 2010 Pages: 497 - 502
The Omega-3 Index: Clinical Utility for Therapeutic Intervention William S. Harris ReviewPaper 01 September 2010 Pages: 503 - 508